4577
Daito Pharmaceutical Co.,Ltd.
ダイト
- Industry
- Pharmaceutical
- Market
- Prime
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Notes
- Stock adjustmentsSep 1, 2023 Stock split 1 share → 1.1 shares
- Stock adjustmentsJun 1, 2025 Stock split 1 share → 2 shares
Key metrics
Revenue(million JPY)
May 2022
43,464
May 2023
45,101
May 2024
46,895
May 2025
50,643
May 2026
50,650
Operating profit(million JPY)
May 2022
6,553
May 2023
5,207
May 2024
3,894
May 2025
2,619
May 2026
3,637
Operating profit margin(%)
May 2022
15.08
May 2023
11.55
May 2024
8.3
May 2025
5.17
May 2026
7.18
Profit before tax(million JPY)
May 2022
6,720
May 2023
5,076
May 2024
4,218
May 2025
2,958
May 2026
4,065
Profit(million JPY)
May 2022
4,668
May 2023
3,600
May 2024
3,295
May 2025
1,908
May 2026
3,161
Total assets(million JPY)
May 2022
64,939
May 2023
70,552
May 2024
77,708
May 2025
78,004
May 2026
73,291
Cash and cash equivalents(million JPY)
May 2022
4,381
May 2023
3,607
May 2024
2,727
May 2025
2,207
May 2026
954
Cash flows from operating activities(million JPY)
May 2022
4,370
May 2023
4,155
May 2024
5,182
May 2025
5,897
May 2026
9,377
Cash flows from investing activities(million JPY)
May 2022
-4,400
May 2023
-5,566
May 2024
-5,930
May 2025
-7,365
May 2026
-4,388
Cash flows from financing activities(million JPY)
May 2022
989
May 2023
616
May 2024
-183
May 2025
1,002
May 2026
-6,289
Return on equity(%)
May 2022
10.5
May 2023
7.3
May 2024
6.4
May 2025
3.7
May 2026
6
Equity ratio(%)
May 2022
72.8
May 2023
71.8
May 2024
67
May 2025
66.7
May 2026
72.2
Earnings per share(JPY per share)
May 2022
152.4591
May 2023
113.8136
May 2024
105
May 2025
31.37
May 2026
107.49
Net assets per share(JPY per share)
May 2022
1,504.7
May 2023
1,603.25
May 2024
1,702.35
May 2025
867.13
May 2026
1,840.13
Dividend per share(JPY per share)
May 2022
27.2727
May 2023
27.2727
May 2024
30
May 2025
35
May 2026
40
Payout ratio(%)
May 2022
17.89
May 2023
23.96
May 2024
28.57
May 2025
111.57
May 2026
37.21
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.